Ansell Ltd (ASX: ANN) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ansell Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.89 billion
P/E Ratio 21.97
Dividend Yield 2.45%
Shares Outstanding 145.94 million
Earnings per share 0.818
Dividend per share 0.66
Year To Date Return 7.12%
Earnings Yield 4.55%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ansell Ltd (ASX: ANN)
    Latest News

    Lion roaring in the wild, symbolising a rising Liontown share price.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    ASX investors once again pulled back from record highs today.

    Read more »

    Health professional putting on gloves.
    Healthcare Shares

    Why are Ansell shares on investors' radars today?

    Management sees the deal growing sales and earnings.

    Read more »

    Modern accountant woman in a light business suit in modern green office with documents and laptop.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was back to the races for ASX shares this Wednesday.

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    Share Market News

    Here are the top 10 ASX 200 shares today

    It was a third day of gains in a row for ASX 200 shares today.

    Read more »

    A man sits thoughtfully on the couch with a laptop on his lap.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a strong showing from ASX shares this Tuesday.

    Read more »

    two people celebrating good news, stock rise, price increase, positive announcement
    Share Gainers

    Why Ansell, Elders, Predictive Discovery, and Rio Tinto shares are storming higher

    These ASX shares are having a strong session. But why?

    Read more »

    Graincorp share price farming asx share price rise represented by rejoicing farmer in field
    Broker Notes

    These 2 ASX 200 shares just got big upgrades from top brokers

    The brokers believe both ASX 200 shares are undervalued at current levels.

    Read more »

    A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
    Consumer Staples & Discretionary Shares

    Ansell shares jump 14% amid blockbuster acquisition

    Ansell is making a big acquisition and it could be a big boost to its earnings.

    Read more »

    Health professional putting on gloves.
    Mergers & Acquisitions

    Ansell share price hits pause as company gloves up for $975 million acquisition

    Ansell shares won't be trading for a while...

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was back to reality for ASX shares this hump day.

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    The ASX enjoyed a strong open to the trading week today.

    Read more »

    A man closesly watch a clock, indicating a delay or timing issue on an ASX share price movement
    Dividend Investing

    25 ASX 200 shares with ex-dividend dates next week

    There are 25 ASX 200 shares scheduled to go 'ex-div' next week.

    Read more »

    Frequently Asked Questions

    Yes, Ansell has historically paid two unfranked or partially franked dividends per year.

    Ansell pays its shareholder dividends in March and September.

    Ansell Ltd listed on the ASX on 22 August 1985.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    26 Feb 2024 $0.2521 0.00% Interim 14 Mar 2024
    18 Aug 2023 $0.4031 0.00% Final 07 Sep 2023
    20 Feb 2023 $0.2915 0.00% Interim 09 Mar 2023
    29 Aug 2022 $0.4518 0.00% Final 15 Sep 2022
    21 Feb 2022 $0.3367 0.00% Interim 09 Mar 2022
    30 Aug 2021 $0.5944 0.00% Final 16 Sep 2021
    22 Feb 2021 $0.4190 0.00% Interim 10 Mar 2021
    31 Aug 2020 $0.3811 0.00% Final 17 Sep 2020
    24 Feb 2020 $0.3288 0.00% Interim 12 Mar 2020
    16 Aug 2019 $0.3833 0.00% Final 05 Sep 2019
    22 Feb 2019 $0.2905 0.00% Interim 14 Mar 2019
    24 Aug 2018 $0.3414 0.00% Final 13 Sep 2018
    16 Feb 2018 $0.2588 44.13% Interim 08 Mar 2018
    18 Aug 2017 $0.2998 0.00% Final 08 Sep 2017
    17 Feb 2017 $0.2638 0.00% Interim 10 Mar 2017
    19 Aug 2016 $0.3097 0.00% Final 08 Sep 2016
    11 Feb 2016 $0.2795 0.00% Interim 10 Mar 2016
    13 Aug 2015 $0.3119 0.00% Final 10 Sep 2015
    12 Feb 2015 $0.2567 0.00% Interim 11 Mar 2015
    26 Feb 2014 $0.1828 0.00% Interim 25 Mar 2014
    16 Feb 2012 $0.1050 0.00% Interim 14 Mar 2012
    17 Feb 2011 $0.0980 0.00% Interim 16 Mar 2011
    31 Aug 2010 $0.1225 0.00% Final 29 Sep 2010
    02 Mar 2006 $0.0630 0.00% Interim 07 Apr 2006
    26 Sep 2005 $0.0700 0.00% Final 18 Oct 2005

    ANN ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ansell Ltd

    Ansell Ltd (ASX: ANN) is a leading global supplier of protective gloves and bodywear for use in healthcare and industrial settings.

    The company holds a large number of patents and the majority of sales come from its key branded product ranges. It earns the bulk of its revenue and profit from the healthcare segment and the remainder from its industrial business.

    The Australian company has an international manufacturing and distribution footprint and supplies its products via key partners as well as directly across more than 120 countries.

    Ansell earns the bulk of its revenue from its North American market segment followed by Europe, the Middle East, and Africa. The Asia-Pacific accounts for a relatively small portion of the company's business.

    ANN Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    22 Jul 2024 $26.64 $-0.08 -0.30% 290,509 $26.58 $26.72 $26.43
    19 Jul 2024 $26.72 $0.02 0.07% 392,148 $26.35 $26.75 $26.21
    18 Jul 2024 $26.70 $0.63 2.42% 486,465 $26.22 $26.80 $26.08
    17 Jul 2024 $26.07 $0.55 2.16% 493,877 $25.70 $26.09 $25.48
    16 Jul 2024 $25.52 $-0.30 -1.16% 215,288 $25.88 $26.00 $25.49
    15 Jul 2024 $25.82 $-0.14 -0.54% 280,992 $26.20 $26.25 $25.78
    12 Jul 2024 $25.96 $0.37 1.45% 225,698 $25.87 $25.97 $25.77
    11 Jul 2024 $25.59 $-0.06 -0.23% 265,803 $25.94 $25.97 $25.56
    10 Jul 2024 $25.65 $-0.06 -0.23% 163,597 $25.72 $25.81 $25.43
    09 Jul 2024 $25.71 $0.34 1.34% 346,452 $25.38 $25.74 $25.24
    08 Jul 2024 $25.37 $-0.27 -1.05% 257,806 $25.59 $25.84 $25.19
    05 Jul 2024 $25.64 $-0.44 -1.69% 541,173 $25.88 $26.16 $25.32
    04 Jul 2024 $26.08 $0.11 0.42% 184,608 $26.23 $26.28 $26.08
    03 Jul 2024 $25.97 $0.01 0.04% 229,612 $26.05 $26.09 $25.75
    02 Jul 2024 $25.96 $0.05 0.19% 194,076 $25.70 $25.98 $25.65
    01 Jul 2024 $25.91 $-0.64 -2.41% 210,433 $26.55 $26.58 $25.82
    28 Jun 2024 $26.55 $0.19 0.72% 514,527 $26.36 $26.65 $26.27
    27 Jun 2024 $26.36 $0.16 0.61% 324,510 $25.96 $26.36 $25.93
    26 Jun 2024 $26.20 $-0.15 -0.57% 360,090 $26.48 $26.48 $26.02
    25 Jun 2024 $26.35 $0.01 0.04% 387,797 $26.50 $26.59 $25.65

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    13 May 2024 Nigel Garrard Buy 1,337 $30,015
    Participation in share purchase plan.
    13 May 2024 Debra (Debbie) Goodin Buy 286 $6,420
    Participation in share purchase plan.
    26 Apr 2024 Christina Stercken Buy 627 $15,657
    Participation in share purchase plan.
    12 Apr 2024 Christina Stercken Buy 592 $15,655
    Participation in share purchase plan.
    19 Dec 2023 Neil Salmon Issued 10,198 $244,987
    Issue of securities.
    30 Nov 2023 Neil Salmon Issued 72,263 $1,714,078
    Issue of securities. 167,791 - PSRs
    23 Nov 2023 Christina Stercken Buy 285 $6,499
    Participation in share purchase plan.
    06 Nov 2023 Christina Stercken Buy 294 $6,491
    Participation in share purchase plan.
    30 Oct 2023 Christina Stercken Buy 800 $16,880
    On-market trade.
    27 Oct 2023 Nigel Garrard Buy 1,250 $26,500
    On-market trade.
    12 Sep 2023 Christina Stercken Buy 837 $18,742
    Participation in share purchase plan.
    07 Sep 2023 Debra (Debbie) Goodin Buy 8 $1,492
    Dividend Reinvestment Plan (DRP).
    23 Aug 2023 Christine Yan Buy 8,300 $191,893
    On-market trade.
    18 Aug 2023 Neil Salmon Expiry 30,271 $705,011
    As advised by the company. Lapsing of PSRs
    95,428 - PSRs
    18 Aug 2023 Christine Yan Buy 283 $6,670
    Participation in share purchase plan.
    18 Aug 2023 Christina Stercken Buy 260 $6,128
    Participation in share purchase plan.
    18 Aug 2023 John Bevan Buy 172 $4,054
    Participation in share purchase plan.
    18 Aug 2023 Debra (Debbie) Goodin Buy 418 $9,816
    On-market trade.
    17 Aug 2023 Nigel Garrard Buy 1,000 $23,970
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Nigel David Garrard Non-Executive Director Mar 2020
    Mr Garrard is an executive who has worked across FMCG and Industrial/ Manufacturing sectors. Mr Garrard has 20 years of experience as an ASX-listed CEO across three companies. In 2019, Mr Garrard retired as Managing Director and CEO of Orora Limited. Mr Garrard led the demerger of Orora from Amcor, and subsequent listing on the ASX in 2013. Mr Garrard brings international experience across listed, not-for-profit, governance, private and industry entities. He is the Chair of the Human Resources Committee and member of the Sustainability and Risk Committee and Share Buyback Sub-Committee.
    Mr William G Reilly Non-Executive Director Oct 2017
    Mr Reilly has over 35 years of experience as an in-house lawyer. Mr Reilly was appointed as General Counsel of Ansell Healthcare in 2000 when it was a division of Pacific Dunlop Limited, subsequently becoming General Counsel of Ansell Limited in 2002.Mr Reilly has served with three Chief Executive Officers and has played roles leading many of Ansell's corporate strategic and legal initiatives, including M&A, litigation, and the intellectual property strategy. He has also overseen the Global Compliance and Risk functions, acted as interim head of Human Resources, leader of the Regulatory function and joint Company Secretary. He is member of the Sustainability and Risk Committee, the Human Resources Committee, the Governance Committee, and the M&A Sub-Committee.
    Ms Debra (Debbie) Lyn Goodin Non-Executive Director Dec 2022
    Ms Goodin is an executive who has global experience in operations, finance, M&A, and corporate services, and has worked in both the public and private sectors. In 2014 she completed a 22-month contract role with Downer Group (ASX 100) as Divisional CEO/COO of Downer's two consulting subsidiary companies in New Zealand and Australia. Prior to this Ms Goodin was the Global COO of Coffey International where she led a range of engineering consulting businesses in the areas of mining, geotechnics, environment, and international development. She is also member of the Compliance Committee and the Human Resources Committee.
    Ms Leslie A Desjardins Non-Executive Director Nov 2015
    Mrs Desjardins is a former international finance executive with experience in business performance and growth. Mrs Desjardins was formerly the Chief Financial Officer of Amcor Limited. Prior to Amcor, she held executive roles at General Motors Corporation, in Canada, the United States and Australia, including Chief Financial Officer GM Holden, Controller for GM North America and Finance Director for GM's manufacturing facilities in North America. Mrs Desjardins has experience in finance, M&A, strategy, government relations and global operations. She is the Chair of Compliance Committee, member of the Human Resources Committee and the Governance Committee, M&A Sub-Committee and Share Buyback Sub-Committee.
    Mrs Christina Stercken Non-Executive Director Oct 2017
    Mrs Stercken was a partner at Euro Asia Consulting PartG (EAC) until the end of 2017. In this function, Mrs Stercken helped customers in machinery, automotive, chemical, healthcare and infrastructure industries in strategy, M&A, and operational excellence in growth markets. Before joining EAC, Mrs Stercken served as Managing Director Corporate Finance M&A of Siemens AG. Among other management positions within Siemens AG, she was responsible for the Siemens Task Force China and Head of Public Sector Business Unit at Siemens Business Services. Mrs Stercken started her career in Marketing at BMW Pty. Ltd, South Africa. Mrs Stercken brings a range of competencies relevant to Ansell's strategies, including M&A, broad industry background and business building in developing markets. She is Chair of the Sustainability and Risk Committee and M&A Sub-Committee and member of the Compliance Committee.
    Ms Christine Yingli Yan Non-Executive Director Feb 2019
    Ms Yan is an executive who has had a career at Stanley Black & Decker. Ms Yan has held senior management positions in both the US and China, including Vice President of Sales and Marketing for North America Automotive, President of the Global Automotive Division, President of Americas for the Engineered Fastening division, President of Stanley Storage and Workspace Systems and more recently, President of Asia and Vice President of Integration. Ms Yan brings range of general management experience across different geographies, as well as experience in innovation, business development, sales, digital transformation, and marketing in the business-to- business industry. He is member of the Human Resources Committee and the Governance Committee.
    Mr Neil Salmon Chief Executive OfficerManaging Director Sep 2021
    Mr Salmon had more than 20 years of experience, gained working across a range of roles in a diverse group of international businesses. He spent the first 17 years of his career with Imperial Chemical Industries (ICI) primarily in finance roles based in the UK, South Africa, the USA, and Singapore before serving as Chief Financial Officer of Innophos in New Jersey, USA. Having led Ansell's 7,500 IGBU workforce through a challenging global economic climate, Neil was a contributor to strategies that have allowed the company to pursue its growth trajectory in recent times, notably at the onset of the COVID-19 pandemic. As CEO, he oversees the Company's further strategic development, with a focus on continued innovation and increased sustainability.
    Morten Falkenberg Non-Executive Director Nov 2021
    Mr Falkenberg is an executive with nearly 35 years of leadership experience within FMCG, Telecoms/ Technology, and consumer durable goods companies most recently as CEO of Nobia (Europe's kitchen company) from 2010 until his retirement in 2019. Prior to that Mr Falkenberg held senior positions at Electrolux, Tele Denmark and Coca-Cola and has lived outside his native Denmark in the USA, Israel, Norway, and Sweden. He is also Member of the Compliance Committee and the Sustainability and Risk Committee.
    Ms Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary Apr 2017
    -
    Renae Leary Chief Commercial Officer - Americas
    -
    Francois le Jeune Chief Commercial Officer EMEA and APAC and Guardian Administration
    -
    Zubair Javeed Chief Financial Officer
    -
    Amanda Manzoni Chief Human Resources Officer
    -
    Michael Gilleece Corporate General Counsel
    -
    Deanna Johnston Global Chief Information Officer
    -
    Darryl Nazareth President of the Healthcare GBU
    -
    Rikard Froberg President of the Industrial GBU
    -
    Augusto Accorsi SBU Vice President and GM HGBU Exam and Single Use
    -
    Angie Phillips SBU Vice President and GM HGBU Surgical and HSS
    -
    Evren Baykal SBU Vice President and GM IGBU Chemical Solutions
    -
    Sean Sweeney SBU Vice President and GM IGBU Mechanical Solutions
    -
    John Marsden Senior Vice President - Global Operations and Global Supply Chain
    -
    Catherine Stribley VP Corporate Governance & Social ResponsibilityCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 33,834,602 26.68%
    Citicorp Nominees Pty Limited 19,795,585 15.61%
    J P Morgan Nominees Australia Pty Limited 19,427,724 15.32%
    BNP Paribas Noms Pty Ltd <Drp> 5,716,599 4.51%
    National Nominees Limited 5,681,579 4.48%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 905,971 0.71%
    Australian Foundation Investment Company Limited 870,000 0.69%
    Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 820,538 0.65%
    CPU Share Plans Pty Ltd 800,144 0.63%
    Netwealth Investments Limited <Wrap Services A/C> 597,014 0.47%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 386,079 0.31%
    HSBC Custody Nominees (Australia) Limited i 314,117 0.25%
    IOOF Investment Services Limited <IPS Superfund A/C> 303,084 0.24%
    Netwealth Investments Limited <Super Services A/C> 296,305 0.23%
    Citicorp Nominees Pty Limited <Citibank NY ADR Dep A/C> 288,540 0.23%
    The Pavilion Motor Inn of Wagga Wagga Pty Ltd 285,000 0.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 231,474 0.18%
    The Manly Hotels Pty Limited 222,854 0.18%
    HSBC Custody Nominees (Australia) Limited A/C 2 220,184 0.17%
    Australian Executor Trustees Limited <No 1 Account> 178,886 0.14%

    Profile

    since

    Note